Adipose-derived autologous stem cell therapy - U.S. Stem Cell

Drug Profile

Adipose-derived autologous stem cell therapy - U.S. Stem Cell

Alternative Names: AdipoCell (Bioheart); Bioheart Acute Cell Therapy; Implanted autologous adipose-derived stem cells - U.S. Stem Cell; LipiCell

Latest Information Update: 27 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bioheart
  • Developer Magnum Cell Therapies; Revita Life Sciences; U.S. Stem Cell
  • Class Anti-ischaemics; Cardiovascular therapies; Erectile dysfunction therapies; Eye disorder therapies; Heart failure therapies; Stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Intervertebral disc degeneration
  • Phase I/II Heart failure
  • Phase I Osteoarthritis
  • Clinical Phase Unknown Chronic obstructive pulmonary disease; Coronary disorders; Erectile dysfunction; Myocardial ischaemia; Peripheral ischaemia; Psoriasis
  • No development reported Myocardial infarction

Most Recent Events

  • 21 Mar 2018 Efficacy data from a clinical trial in Psoriasis released by U.S Stem Cell
  • 01 Jan 2018 Clinical trials in Psoriasis (IV), before January 2018
  • 28 Nov 2017 Efficacy and adverse event data from a phase II trial in Intervertebral disc degeneration released by U.S. Stem Cell
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top